Thomas Woiwode
CIK 1619294 · last filed 2023-05-26
Thomas Woiwode is a corporate insider who has filed 49 SEC Form 4 insider transactions across 8 companies since 2016. The most recent filing, for PASG, was dated May 26, 2023. Across all open-market trades the lifetime net is −$7.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $31.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$31.28M
8
49
-$7.95M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PASG | Director | 35,418 | $4.57 | $161.9K | $4.05M | 5 | 2023-05-26 |
| ALGS | Director | 58,495 | $4.25 | $248.6K | $3.00M | 5 | 2022-06-27 |
| TPST | Director | 180,168 | $0.87 | $156.9K | $5.00M | 5 | 2022-06-22 |
| Gritstone bio, Inc. (GRTS) Delisted | Director | 6,740 | $0.03 | $217 | $5.00M | 5 | 2021-08-27 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | 1,882 | $4.36 | $8.2K | $0 | 14 | 2021-05-14 |
| CRSP | Director | 645,643 | $47.55 | $30.70M | -$27.67M | 7 | 2018-06-15 |
| CRISPR Therapeutics AG (PZRX) Delisted | Director | 4,959 | — | — | $2.15M | 6 | 2017-12-27 |
| BOLD | Director | 6,811 | $2.47 | $16.8K | $525.0K | 2 | 2016-08-25 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-26 | PASG | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | ALGS | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | TPST | Grant (A) | — | $0 | EDGAR |
| 2022-05-31 | PASG | Grant (A) | — | $0 | EDGAR |
| 2022-05-03 | TPST | Buy (P) | +2,118,644 | $5.00M | EDGAR |
| 2021-09-20 | TPST | Grant (A) | — | $0 | EDGAR |
| 2021-08-27 | Gritstone bio, Inc. (GRTS) Delisted | Other (J) | −444,616 | $0 | EDGAR |
| 2021-07-06 | TPST | Grant (A) | — | $0 | EDGAR |
| 2021-06-29 | TPST | Grant (A) | +2,176,411 | $0 | EDGAR |
| 2021-06-17 | ALGS | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.